Zobrazeno 1 - 10
of 132
pro vyhledávání: '"A. L. Moores"'
Autor:
Ricardo Rivera-Soto, Benjamin Henley, Marian A. Pulgar, Stacey L. Lehman, Himanshu Gupta, Kia Z. Perez-Vale, Megan Weindorfer, Smruthi Vijayaraghavan, Tsun-Wen Sheena Yao, Sylvie Laquerre, Sheri L. Moores
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-13 (2024)
Abstract Amivantamab is an FDA-approved bispecific antibody targeting EGF and Met receptors, with clinical activity against EGFR mutant non-small cell lung cancer (NSCLC). Amivantamab efficacy has been demonstrated to be linked to three mechanisms of
Externí odkaz:
https://doaj.org/article/dd29589b1b0e4788a2ded682757cbef6
Publikováno v:
Animals, Vol 13, Iss 24, p 3843 (2023)
The most common bacterial isolates in dogs with pyothorax include mixed anaerobes, Enterobacteriaceae (especially Escherichia coli), Pasteurella spp., Streptococcus spp., and Staphylococcus spp. A fluoroquinolone with amoxicillin (±clavulanate) or a
Externí odkaz:
https://doaj.org/article/83894e33931948e0894e16c784c7f911
Publikováno v:
Occupational Medicine. 73:103-108
Background Critical incident debriefs are a commonly used occupational health tool for supporting staff after traumatic work incidents. However, there is a dearth of literature evaluating training programmes for debrief facilitators. Aims To evaluate
Autor:
Forest M. White, Sylvie Laquerre, Sheri L. Moores, Rebecca S. Lescarbeau, Raven J. Reddy, Antje Dittmann, Kristina B. Emdal
Summary of data from target efficacy evaluation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::253ca0c0a757fe430c84569288afdef8
https://doi.org/10.1158/1535-7163.22508673.v1
https://doi.org/10.1158/1535-7163.22508673.v1
Autor:
Sheri L. Moores, Sylvie Laquerre, Matthew V. Lorenzi, Kathryn Packman, Hillary J. Millar, Marilda Beqiri, Jocelyn Sendecki, Ryan Lenhart, Benjamin Henley, Barbara S. Bushey, Kristen Chevalier, Lorraine Lipfert, Smruthi Vijayaraghavan
Live cell imaging of M2 macrophage mediated trogocytosis in adherent co-culture
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cf87af4285c3d0237f323a012dd937b
https://doi.org/10.1158/1535-7163.22518970.v1
https://doi.org/10.1158/1535-7163.22518970.v1
Autor:
Sheri L. Moores, Sylvie Laquerre, Matthew V. Lorenzi, Kathryn Packman, Hillary J. Millar, Marilda Beqiri, Jocelyn Sendecki, Ryan Lenhart, Benjamin Henley, Barbara S. Bushey, Kristen Chevalier, Lorraine Lipfert, Smruthi Vijayaraghavan
Contains Supplementary methods, supp figure legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8938da80853fda873f747b0495ab89f0
https://doi.org/10.1158/1535-7163.22518967
https://doi.org/10.1158/1535-7163.22518967
Autor:
Sheri L. Moores, Sylvie Laquerre, Matthew V. Lorenzi, Kathryn Packman, Hillary J. Millar, Marilda Beqiri, Jocelyn Sendecki, Ryan Lenhart, Benjamin Henley, Barbara S. Bushey, Kristen Chevalier, Lorraine Lipfert, Smruthi Vijayaraghavan
Small molecule inhibitors targeting mutant EGFR are standard of care in non–small cell lung cancer (NSCLC), but acquired resistance invariably develops through mutations in EGFR or through activation of compensatory pathways such as cMet. Amivantam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04bfc5a7fffe067a0b3eccd7a83c5d4b
https://doi.org/10.1158/1535-7163.c.6542206.v1
https://doi.org/10.1158/1535-7163.c.6542206.v1
Autor:
Sheri L. Moores, Sylvie Laquerre, Matthew V. Lorenzi, Kathryn Packman, Hillary J. Millar, Marilda Beqiri, Jocelyn Sendecki, Ryan Lenhart, Benjamin Henley, Barbara S. Bushey, Kristen Chevalier, Lorraine Lipfert, Smruthi Vijayaraghavan
Contains supp figures S1-S13 and the corresponding figure legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::824a5bfa7ec2d672467f396f79661a66
https://doi.org/10.1158/1535-7163.22518991.v1
https://doi.org/10.1158/1535-7163.22518991.v1
Autor:
Forest M. White, Sylvie Laquerre, Sheri L. Moores, Rebecca S. Lescarbeau, Raven J. Reddy, Antje Dittmann, Kristina B. Emdal
Summary of data from drug resistance evaluation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::588576d32a6a5fd2a8a33a064f6428c1
https://doi.org/10.1158/1535-7163.22508679.v1
https://doi.org/10.1158/1535-7163.22508679.v1
Autor:
Forest M. White, Sylvie Laquerre, Sheri L. Moores, Rebecca S. Lescarbeau, Raven J. Reddy, Antje Dittmann, Kristina B. Emdal
Supplementary Figures and Legends to accompany the text
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04f966bd7c061b2529491f976a1d645c
https://doi.org/10.1158/1535-7163.22508682.v1
https://doi.org/10.1158/1535-7163.22508682.v1